Open AccessThe use of intralipid emulsion therapy to treat severe cardiotoxicity secondary to lamotrigine ingestion in a dog
Author(s) -
Bellis Tara J.,
Gibeon Laura
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1733
Subject(s) - lamotrigine , medicine , cardiotoxicity , ingestion , refractory (planetary science) , anesthesia , pharmacology , chemotherapy , epilepsy , psychiatry , physics , astrobiology
Key Clinical Message Lamotrigine is a sodium and calcium channel blocker, used to treat seizures in people. Dogs metabolize Lamotrigine to a cardiotoxic metabolite that causes severe, often fatal ventricular arrhythmias. This report documents the successful treatment of refractory Lamotrigine cardiotoxicity in a dog, using intralipid emulsion therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom